Related Experiment Video
Updated: Oct 2, 2025

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Identifying Inhibitors of -1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses
Sneha Munshi1, Krishna Neupane1, Sandaru M Ileperuma1
1Department of Physics, University of Alberta, Edmonton, AB T6G 2E1, Canada.
Abstract:
Recurrent outbreaks of novel zoonotic coronavirus (CoV) diseases in recent years have highlighted the importance of developing therapeutics with broad-spectrum activity against CoVs. Because all CoVs use -1 programmed ribosomal frameshifting (-1 PRF) to control expression of key viral proteins, the frameshift signal in viral mRNA that stimulates -1 PRF provides a promising potential target for such therapeutics. To test the viability of this strategy, we explored whether small-molecule inhibitors of -1 PRF in SARS-CoV-2 also inhibited -1 PRF in a range of bat CoVs-the most likely source of future zoonoses. Six inhibitors identified in new and previous screens against SARS-CoV-2 were evaluated against the frameshift signals from a panel of representative bat CoVs as well as MERS-CoV. Some drugs had strong activity against subsets of these CoV-derived frameshift signals, while having limited to no effect on -1 PRF caused by frameshift signals from other viruses used as negative controls. Notably, the serine protease inhibitor nafamostat suppressed -1 PRF significantly for multiple CoV-derived frameshift signals. These results suggest it is possible to find small-molecule ligands that inhibit -1 PRF specifically in a broad spectrum of CoVs, establishing frameshift signals as a viable target for developing pan-coronaviral therapeutics.
Insights
Researchers identified small-molecule inhibitors targeting programmed ribosomal frameshifting (-1 PRF) in coronaviruses (CoVs). These inhibitors show potential for broad-spectrum therapeutics against diverse CoVs, including bat CoVs, by targeting viral mRNA frameshift signals.
Area of Science:
- Virology
- Drug Discovery
- Molecular Biology
Background:
- Recurrent zoonotic coronavirus (CoV) outbreaks necessitate broad-spectrum therapeutics.
- Programmed ribosomal frameshifting (-1 PRF) is a conserved mechanism in CoV replication, making its regulatory elements a potential drug target.
Purpose of the Study:
- To investigate if small-molecule inhibitors of SARS-CoV-2 -1 PRF exhibit activity against a range of bat CoVs and MERS-CoV.
- To validate viral mRNA frameshift signals as a viable target for pan-coronaviral therapeutics.
Main Methods:
- Evaluation of six SARS-CoV-2 -1 PRF inhibitors against frameshift signals from various bat CoVs and MERS-CoV.
- Utilized negative control viruses to assess specificity of inhibitor activity.
Main Results:
- Some inhibitors demonstrated potent activity against specific subsets of CoV -1 PRF signals.
- The serine protease inhibitor nafamostat significantly suppressed -1 PRF in multiple CoV frameshift signals.
- Inhibitor activity was specific, with limited effects on negative control viruses.
Conclusions:
- Small-molecule ligands can be developed to specifically inhibit -1 PRF across a broad spectrum of CoVs.
- Viral frameshift signals represent a promising and viable target for the development of pan-coronaviral therapeutics.
More Related Videos
Related Concept Videos
Leaky Scanning
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Viruses with RNA Genomes
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Ribozymes
Ribozymes can...

